Darya Chudova

USPTO Granted Patents = 48 (Patent Applications = 42)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 3.6

ph-index = 12

Forward Citations = 428(Granted Patents)

Company Filing History:

26 out of 122

Guardant Health, Inc.

Verinata Health, Inc.

Years Active: 2013-2025

Loading Chart...

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12385097 - Normalizing tumor mutation burden (2025-08-12),

2. 12344902 - Microsatellite instability detection in cell-free DNA (2025-07-01),

3. 12340873 - Methods for multi-resolution analysis of cell-free nucleic acids (2025-06-24),

4. 12305238 - Methods for treatment of thyroid cancer (2025-05-20),

5. 12297503 - Methods for classification of tissue samples as positive or negative for cancer (2025-05-13),

6. 12291751 - Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage (2025-05-06),

7. 12288598 - Computational modeling of loss of function based on allelic frequency (2025-04-29),

8. 12241128 - Methods for early detection of cancer (2025-03-04),

9. 12217827 - Detecting fetal sub-chromosomal aneuploidies (2025-02-04),

10. 12116640 - Methods for early detection of cancer (2024-10-15),

11. 12110554 - Methods for classification of tissue samples as positive or negative for cancer (2024-10-08),

12. 12106825 - Computational modeling of loss of function based on allelic frequency (2024-10-01),

13. 12100482 - Methods for multi-resolution analysis of cell-free nucleic acids (2024-09-24),

14. 12094573 - Methods for multi-resolution analysis of cell-free nucleic acids (2024-09-17),

15. 11827942 - Methods for early detection of cancer (2023-11-28),

Title: The Innovative Mind of Darya Chudova

Introduction

Darya Chudova, a prominent inventor based in San Jose, California, has made remarkable contributions to the field of cancer diagnostics. With a total of 39 patents to his name, he stands out as a leading figure in innovation directed towards improving early detection methodologies for cancer.

Latest Patents

Chudova's latest patents focus on groundbreaking methods for the early detection of cancer. One of his notable inventions involves innovative techniques for preparing cell-free nucleic acid molecules from patients for sequencing. This method facilitates the sequencing of specific regions in these molecules, allowing for the detection of vital cancer markers. Another significant patent relates to the classification of tissue samples, where he developed comprehensive compositions and kits for molecular profiling. His work specifically addresses genomic DNA markers associated with thyroid cancer, providing a sophisticated method for diagnosis through detailed molecular profiles.

Career Highlights

Throughout his career, Chudova has worked with leading companies in the healthcare technology sector, including Guardant Health and Veracyte. His experience in these organizations allowed him to combine his research with practical applications, driving innovations that have a direct impact on patient care and cancer detection.

Collaborations

Chudova collaborates with notable peers in the industry, including Stefanie Ann Ward Mortimer and Giulia C. Kennedy. These collaborations reflect a rich diversity of expertise, contributing to the development of advanced solutions to combat cancer effectively.

Conclusion

Darya Chudova's dedication to innovation in cancer diagnostics exemplifies the spirit of modern invention. His impressive patent portfolio and collaborative efforts with industry professionals underscore the importance of continued research and development in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.